PPARgamma-mediated insulin sensitization: the importance of fat versus muscle (Q36002095)

11 August 2017

1 reference

title

PPARgamma-mediated insulin sensitization: the importance of fat versus muscle (English)

1 reference

11 August 2017

1 reference

1

Ulrich Kintscher

1 reference

11 August 2017

Ronald E Law

2

1 reference

11 August 2017

1 February 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

11 August 2017

1 reference

11 August 2017

288

1 reference

11 August 2017

E287-91

1 reference

11 August 2017

2

1 reference

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

11 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Muscle-specific Pparg deletion causes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

TGF-beta(1) induces peroxisome proliferator-activated receptor gamma1 and gamma2 expression in human THP-1 monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Regulation of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Life without white fat: a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00440.2004

10.1152/AJPENDO.00440.2004

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15637349